Ways and Means Committee, Health Subcommittee, Energy and Commerce Committee
Introduced
In Committee
On Floor
Passed Chamber
Enacted
Medicare and Opioid Safe Treatment Act or the MOST Act This bill establishes several requirements for the Centers for Medicare & Medicaid Services (CMS), and alters requirements under Medicare and Medicare Advantage, related to pain management and opioid use. For example, the bill requires certified opioid treatment program services to be covered under Medicare. Additionally, among other requirements, the CMS must review payments under Medicare for opioid and non-opioid pain management procedures, specifically with respect to ambulatory outpatient surgical procedures and hospital outpatient department services. The CMS must ensure that there are no payment incentives for using opioids instead of non-opioid alternatives and must make revisions accordingly. The bill also requires payment under Medicare to federally qualified health centers and rural health clinics that have health care practitioners who are newly certified to provide medication-assisted treatment (e.g., buprenorphine).
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-764, Part I.
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Alternative treatmentsCongressional oversightDrug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesGovernment information and archivesGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHealth facilities and institutionsHealth personnelHealth programs administration and fundingHealth technology, devices, suppliesHome and outpatient careHospital careMedical tests and diagnostic methodsMedicareMental healthRural conditions and developmentSurgery and anesthesia
To amend title XVIII to provide for Medicare coverage of certain services furnished by opioid treatment programs, and for other purposes.
USA115th CongressHR-5776| House
| Updated: 6/19/2018
Medicare and Opioid Safe Treatment Act or the MOST Act This bill establishes several requirements for the Centers for Medicare & Medicaid Services (CMS), and alters requirements under Medicare and Medicare Advantage, related to pain management and opioid use. For example, the bill requires certified opioid treatment program services to be covered under Medicare. Additionally, among other requirements, the CMS must review payments under Medicare for opioid and non-opioid pain management procedures, specifically with respect to ambulatory outpatient surgical procedures and hospital outpatient department services. The CMS must ensure that there are no payment incentives for using opioids instead of non-opioid alternatives and must make revisions accordingly. The bill also requires payment under Medicare to federally qualified health centers and rural health clinics that have health care practitioners who are newly certified to provide medication-assisted treatment (e.g., buprenorphine).
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Reported (Amended) by the Committee on Ways and Means. H. Rept. 115-764, Part I.
Introduced in House
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Alternative treatmentsCongressional oversightDrug, alcohol, tobacco useDrug therapyDrug trafficking and controlled substancesGovernment information and archivesGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHealth facilities and institutionsHealth personnelHealth programs administration and fundingHealth technology, devices, suppliesHome and outpatient careHospital careMedical tests and diagnostic methodsMedicareMental healthRural conditions and developmentSurgery and anesthesia